100% confidential Case Evaluations
Answer a few basic questions to get started
Receive a confidential case evaluation
Have an individual claim filed for compensation
Billions in profits made on unsafe Medication
How does Zantac® (aka ranitidine®) cause esophageal cancer?
Beginning in 1983, Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® to reduce excess acid produced in stomach cells.
It was initially approved only for short-term use by the Federal Drug Administration (FDA) due to its potential to cause cancer in long-term use–however, Zantac® began being marketed for long-term use.
Since over-the-counter Zantac® (aka ranitidine®) contains dangerously high levels of the chemical N-nitrosodimethylamine (NDMA), it has potentially been linked to several types of lifelong cancers–namely esophageal cancer.
Shield Legal Network believes that esophageal cancer victims should get the compensation and justice they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law.
Zantac® and Esophageal Cancer in the News
2020
According to a recently filed product liability lawsuit, the side effects of Zantac® caused a Virginia woman to develop esophageal cancer, due to carcinogenic chemicals produced by the recalled heartburn drug.
2019
Zantac users who have developed cancer are filing lawsuits against the drug’s manufacturers on several counts including Negligence, Strict Liability - Design Defect, and Strict Liability - Failure to warn.
2016
Donald Boland of Florida was diagnosed with esophageal cancer after taking Zantac three times a day since 2002.